Status:
UNKNOWN
The Application of SERS and Metabolomics in Sepsis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Sepsis
Eligibility:
All Genders
Brief Summary
It has always been a real challenge to treat sepsis in critically ill patients. The mortality is as high as 20％ in patients with severe sepsis and 46％ with septic shock develops. Early diagnosis and e...
Detailed Description
Sepsis is a serious medical condition caused by an overwhelming immune response to infection. Different series of chemicals released into the blood to fight infection trigger systemic inflammation, wh...
Eligibility Criteria
Inclusion
- \- Any hospitalized patient with
- Septic shock
- Before the use of parenteral or systemic antimicrobial therapy
Exclusion
- Pregnant women
- Organ transplantation
- Cancer
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02213237
Start Date
July 1 2011
End Date
December 1 2018
Last Update
December 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan